CHWY - Chewy, Inc. Stock Analysis | Stock Taper
Logo
Chewy, Inc.

CHWY

Chewy, Inc. NYSE
$27.16 -0.06% (-0.02)

Market Cap $11.25 B
52w High $48.62
52w Low $22.74
P/E 52.22
Volume 8.11M
Outstanding Shares 414.10M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $3.26B $873M $39.2M 1.2% $0.09 $86.7M
Q3-2025 $3.12B $863M $59.2M 1.9% $0.14 $65.2M
Q2-2025 $3.1B $872.5M $62M 2% $0.15 $136.1M
Q1-2025 $3.12B $846.9M $62.4M 2% $0.15 $109.2M
Q4-2024 $3.25B $935.72M $22.79M 0.7% $0.06 $27.75M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $878.8M $3.59B $3.1B $497.9M
Q3-2025 $701.5M $3.29B $2.83B $469.4M
Q2-2025 $591.8M $3.12B $2.73B $389.9M
Q1-2025 $616.4M $3.06B $2.68B $375.6M
Q4-2024 $596.66M $3.01B $2.75B $261.46M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $39.2M $263.4M $-23.9M $-55M $184.7M $232M
Q3-2025 $59.2M $207.9M $-57M $-67M $83.6M $175.8M
Q2-2025 $62M $133.9M $-29.7M $-129M $-24.6M $105.9M
Q1-2025 $62.4M $86.4M $-41.2M $-25M $20.6M $48.7M
Q4-2024 $22.79M $207.52M $-50.91M $-67M $89.13M $156.6M

Revenue by Products

Product Q1-2025Q2-2025Q4-2025
Reportable Segment
Reportable Segment
$3.12Bn $3.10Bn $6.38Bn

Q3 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Chewy, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Chewy combines a large and loyal customer base with strong brand recognition, a convenient subscription‑driven model, and a growing ecosystem around pet health and services. It shows healthy gross margins for a retailer, strong operating and free cash flow, a net cash balance sheet, and a culture of customer service and data‑driven personalization that supports high engagement and recurring revenue.

! Risks

The main concerns are structurally thin operating and net margins, a history of accumulated losses, and somewhat tight short‑term liquidity ratios. The business operates in an intensely competitive market with constant pressure on prices and shipping economics, and its expansion into healthcare and vet services adds regulatory, execution, and capital allocation risk. The lack of explicitly reported R&D also raises questions about how consistently innovation spending is prioritized versus near‑term cost control.

Outlook

Looking forward, Chewy’s outlook depends on its ability to translate scale, customer loyalty, and ecosystem expansion into clearer, sustainable profitability. If it can continue to grow high‑margin services like pharmacy, advertising, and health, while tightening cost discipline in logistics and overhead, its financial profile could gradually strengthen. At the same time, competition, cost inflation, and execution complexity mean that progress is unlikely to be linear, and results may remain sensitive to how effectively management balances growth investments with profit improvement.